His repeated ER visits weren’t about individual failure; they reflected structural barriers — transportation, access, work ...
A major new review found that the timing of exercise can, in some instances, meaningfully influence how that exercise affects ...
Novo Nordisk (NYSE:NVO) is advancing etavopivat through late stage clinical trials as a potential therapy for thalassemia. The treatment is under ongoing regulatory review, focused on both beta and ...
Dogwood licensed SP16 to treat cancer-related pain from partner and regulatory sponsor Serpin Pharma The SP16 Phase 1b trial fully funded by the National Cancer Institute; Patient enrollment expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results